Logo image of OCI.AS

OCI NV (OCI.AS) Stock Fundamental Analysis

AMS:OCI - Euronext Amsterdam - NL0010558797 - Common Stock - Currency: EUR

7.54  -0.03 (-0.33%)

Fundamental Rating

3

OCI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 68 industry peers in the Chemicals industry. OCI may be in some trouble as it scores bad on both profitability and health. OCI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year OCI has reported negative net income.
In the past year OCI had a positive cash flow from operations.
In multiple years OCI reported negative net income over the last 5 years.
Each year in the past 5 years OCI had a positive operating cash flow.
OCI.AS Yearly Net Income VS EBIT VS OCF VS FCFOCI.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

1.2 Ratios

OCI has a Return On Assets of -5.28%. This is in the lower half of the industry: OCI underperforms 70.59% of its industry peers.
Looking at the Return On Equity, with a value of -51.53%, OCI is doing worse than 83.82% of the companies in the same industry.
Industry RankSector Rank
ROA -5.28%
ROE -51.53%
ROIC N/A
ROA(3y)41.1%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
OCI.AS Yearly ROA, ROE, ROICOCI.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200

1.3 Margins

In the last couple of years the Profit Margin of OCI has grown nicely.
OCI's Gross Margin of 2.23% is on the low side compared to the rest of the industry. OCI is outperformed by 86.76% of its industry peers.
In the last couple of years the Gross Margin of OCI has declined.
OCI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
OCI.AS Yearly Profit, Operating, Gross MarginsOCI.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400 500

More info and screens

3

2. Health

2.1 Basic Checks

OCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OCI remains at a similar level compared to 1 year ago.
OCI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, OCI has an improved debt to assets ratio.
OCI.AS Yearly Shares OutstandingOCI.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
OCI.AS Yearly Total Debt VS Total AssetsOCI.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 0.20, we must say that OCI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of OCI (0.20) is worse than 83.82% of its industry peers.
OCI has a debt to FCF ratio of 44.52. This is a negative value and a sign of low solvency as OCI would need 44.52 years to pay back of all of its debts.
OCI's Debt to FCF ratio of 44.52 is in line compared to the rest of the industry. OCI outperforms 47.06% of its industry peers.
A Debt/Equity ratio of 2.03 is on the high side and indicates that OCI has dependencies on debt financing.
OCI's Debt to Equity ratio of 2.03 is on the low side compared to the rest of the industry. OCI is outperformed by 89.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.03
Debt/FCF 44.53
Altman-Z 0.2
ROIC/WACCN/A
WACC5.92%
OCI.AS Yearly LT Debt VS Equity VS FCFOCI.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

OCI has a Current Ratio of 1.39. This is a normal value and indicates that OCI is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of OCI (1.39) is worse than 66.18% of its industry peers.
OCI has a Quick Ratio of 1.37. This is a normal value and indicates that OCI is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.37, OCI is doing good in the industry, outperforming 70.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.37
OCI.AS Yearly Current Assets VS Current LiabilitesOCI.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for OCI have decreased strongly by -123.19% in the last year.
The Earnings Per Share has been growing by 105.88% on average over the past years. This is a very strong growth
OCI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -58.51%.
The Revenue for OCI have been decreasing by -20.30% on average. This is quite bad
EPS 1Y (TTM)-123.19%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%164.52%
Revenue 1Y (TTM)-58.51%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-11.72%

3.2 Future

OCI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 71.49% yearly.
OCI is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -14.70% yearly.
EPS Next Y770.92%
EPS Next 2Y251.29%
EPS Next 3Y133.31%
EPS Next 5Y71.49%
Revenue Next Year-33.69%
Revenue Next 2Y-17.08%
Revenue Next 3Y-25.39%
Revenue Next 5Y-14.7%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OCI.AS Yearly Revenue VS EstimatesOCI.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
OCI.AS Yearly EPS VS EstimatesOCI.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OCI. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 19.62, OCI is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as OCI.
The average S&P500 Price/Forward Earnings ratio is at 36.28. OCI is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 19.62
OCI.AS Price Earnings VS Forward Price EarningsOCI.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as OCI.
Industry RankSector Rank
P/FCF 34.14
EV/EBITDA N/A
OCI.AS Per share dataOCI.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
OCI's earnings are expected to grow with 133.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y251.29%
EPS Next 3Y133.31%

More info and screens

0

5. Dividend

5.1 Amount

OCI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OCI NV

AMS:OCI (8/6/2025, 5:35:15 PM)

7.54

-0.03 (-0.33%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-31 2025-07-31
Earnings (Next)11-10 2025-11-10
Inst Owners32.13%
Inst Owner ChangeN/A
Ins Owners8.71%
Ins Owner ChangeN/A
Market Cap1.59B
Analysts73.85
Price Target11.31 (50%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend13.36
Dividend Growth(5Y)N/A
DP-36.26%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)486.8%
Min EPS beat(2)232.01%
Max EPS beat(2)741.58%
EPS beat(4)2
Avg EPS beat(4)85.49%
Min EPS beat(4)-492.57%
Max EPS beat(4)741.58%
EPS beat(8)3
Avg EPS beat(8)31.49%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)37.56%
Min Revenue beat(2)20.15%
Max Revenue beat(2)54.98%
Revenue beat(4)2
Avg Revenue beat(4)8.41%
Min Revenue beat(4)-23.05%
Max Revenue beat(4)54.98%
Revenue beat(8)5
Avg Revenue beat(8)21.58%
Revenue beat(12)9
Avg Revenue beat(12)32.19%
Revenue beat(16)12
Avg Revenue beat(16)36.43%
PT rev (1m)0.1%
PT rev (3m)-19.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-8.14%
Revenue NY rev (3m)-22.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.62
P/S 0.4
P/FCF 34.14
P/OCF 3.33
P/B 2
P/tB 2.12
EV/EBITDA N/A
EPS(TTM)-0.42
EYN/A
EPS(NY)0.38
Fwd EY5.1%
FCF(TTM)0.22
FCFY2.93%
OCF(TTM)2.27
OCFY30.05%
SpS18.65
BVpS3.77
TBVpS3.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.28%
ROE -51.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 2.23%
FCFM 1.18%
ROA(3y)41.1%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
F-Score3
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 2.03
Debt/FCF 44.53
Debt/EBITDA N/A
Cap/Depr -4159.17%
Cap/Sales 10.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 1.37
Altman-Z 0.2
F-Score3
WACC5.92%
ROIC/WACCN/A
Cap/Depr(3y)137.7%
Cap/Depr(5y)97.09%
Cap/Sales(3y)24.99%
Cap/Sales(5y)17.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-123.19%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%164.52%
EPS Next Y770.92%
EPS Next 2Y251.29%
EPS Next 3Y133.31%
EPS Next 5Y71.49%
Revenue 1Y (TTM)-58.51%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-11.72%
Revenue Next Year-33.69%
Revenue Next 2Y-17.08%
Revenue Next 3Y-25.39%
Revenue Next 5Y-14.7%
EBIT growth 1Y-118.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year309.47%
EBIT Next 3Y-17.67%
EBIT Next 5Y-4.61%
FCF growth 1Y-95.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.4%
OCF growth 3Y-68.9%
OCF growth 5Y-27.39%